glp-1 and nerve pain programs the neurovascular landscape: Cell Metabolism The promise and peril of

You might feel nauseous during the first few weeks

PMID: 57 LassenMCHJohansenNDModinDCatarigAMVistisenBKAmadidHet al

As Fillit noted, GLP-1 drugs would be very good candidates to be delivered in combination with an anti-amyloid drug like Eisai and Biogens recently approved Leqembi (lecanemab) or Lillys investigational donanemab, because there is no overlap in the mechanism of action

This complex, comprising NLRC5, ASC, NLRP12, NLRP3, RIPK3, and caspase 8, triggers inflammatory cell death (PANoptosis [pyroptosis, apoptosis, necroptosis]) and the release of cytokines and DAMPs in a manner dependent on TLR2, TLR4, and nicotinamide adenine dinucleotide (NAD + )